Primary Site >> Esophagus Cancer

Gene >> MAPK1

Journal: Int J Cancer. 1998 Oct 29;78(3):366-71.
Title: Suppression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Ras mutant, N116Y.
Author: Senmaru, N|Shichinohe, T|Takeuchi, M|Miyamoto, M|Sazawa, A|Ogiso, Y|Takahashi, T|Okushiba, S|Takimoto, M|Kato, H|Kuzumaki, N
PMID: 9766573
Journal: Oncogene. 2000 Mar 23;19(13):1665-75.
Title: Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Author: Leu, C M|Chang, C|Hu, C
PMID: 10763823
Journal: J Biol Chem. 2001 May 4;276(18):15537-46. Epub 2001 Jan 31.
Title: Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.
Author: Barry, O P|Mullan, B|Sheehan, D|Kazanietz, M G|Shanahan, F|Collins, J K|O'Sullivan, G C
PMID: 11297525
Journal: Oncogene. 2003 Oct 30;22(49):7809-18.
Title: Interleukin-6 acts as an antiapoptotic factor in human esophageal carcinoma cells through the activation of both STAT3 and mitogen-activated protein kinase pathways.
Author: Leu, Chuen-Miin|Wong, Fen-Hwa|Chang, Chungming|Huang, Shiu-Feng|Hu, Cheng-po
PMID: 14586407
Journal: Biochem Pharmacol. 2004 May 1;67(9):1701-10.
Title: Enhancement of peripheral benzodiazepine receptor ligand-induced apoptosis and cell cycle arrest of esophageal cancer cells by simultaneous inhibition of MAPK/ERK kinase.
Author: Sutter, Andreas P|Maaser, Kerstin|Gerst, Bastian|Krahn, Antje|Zeitz, Martin|Scherubl, Hans
PMID: 15081869
Journal: J Biol Chem. 2004 Dec 3;279(49):50676-83. Epub 2004 Sep 16.
Title: The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation.
Author: Chang, Mei-Chi|Wu, Hui-Lin|Lee, Jang-Jaer|Lee, Po-Hsuen|Chang, Hsiao-Hwa|Hahn, Liang-Jiunn|Lin, Bor-Ru|Chen, Yi-Jane|Jeng, Jiiang-Huei
PMID: 15375172
Journal: Carcinogenesis. 2005 Jun;26(6):1035-43. Epub 2005 Feb 17.
Title: Differential requirement of signal pathways for benzo[a]pyrene (B[a]P)-induced nitric oxide synthase (iNOS) in rat esophageal epithelial cells.
Author: Chen, Jingyuan|Yan, Yan|Li, Jingxia|Ma, Qian|Stoner, Gary D|Ye, Jianping|Huang, Chuanshu
PMID: 15718251
Journal: Acta Med Okayama. 2006 Feb;60(1):25-34.
Title: Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro.
Author: Taira, Naruto|Doihara, Hiroyoshi|Oota, Tetsuya|Hara, Fumikata|Shien, Tadahiko|Takahashi, Hirotoshi|Yoshitomi, Seiji|Ishibe, Youichi|Shimizu, Nobuyoshi
PMID: 16508686
Journal: Oncol Rep. 2007 Jan;17(1):161-7.
Title: Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines.
Author: Wada, Yoshiyuki|Yoshida, Kazuhiro|Tsutani, Yasuhiro|Shigematsu, Hideaki|Oeda, Mamoru|Sanada, Yuichi|Suzuki, Takahisa|Mizuiri, Hirozumi|Hamai, Yoichi|Tanabe, Kazuaki|Ukon, Kei|Hihara, Jun
PMID: 17143494
Journal: Am J Gastroenterol. 2008 Apr;103(4):838-41.
Title: Statins in esophageal cancer cell lines: promising lead?
Author: Hawk, Ernest T|Viner, Jaye L
PMID: 18371147
Journal: Mol Cell Biol. 2008 Jun;28(12):4142-51.
Title: Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells.
Author: Miller, Anna V|Alvarez, Sergio E|Spiegel, Sarah|Lebman, Deborah A
PMID: 18426913
Journal: J Cell Biochem. 2008 Sep 1;105(1):53-60.
Title: Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
Author: Liu, Xuan|Wu, William K K|Yu, Le|Sung, Joseph J Y|Srivastava, Gopesh|Zhang, Shu T|Cho, Chi H
PMID: 18452159
Journal: Am J Clin Oncol. 2008 Aug;31(4):329-34.
Title: Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.
Author: Javle, Milind|Pande, Amitkumar|Iyer, Renuka|Yang, Gary|LeVea, Charles|Wilding, Gregory|Black, Jennifer|Nava, Hector|Nwogu, Chukwumere
PMID: 18845990
Journal: J Biol Chem. 2009 Mar 20;284(12):7995-8004.
Title: Sp1 and AP-1 regulate expression of the human gene VIL2 in esophageal carcinoma cells.
Author: Gao, Shu-Ying|Li, En-Min|Cui, Lei|Lu, Xiao-Feng|Meng, Ling-Ying|Yuan, Hua-Min|Xie, Jian-Jun|Du, Ze-Peng|Pang, Jian-Xin|Xu, Li-Yan
PMID: 19164283
Journal: BMC Cancer. 2009 Jun 17;9:190.
Title: Deoxycholate induces COX-2 expression via Erk1/2-, p38-MAPK and AP-1-dependent mechanisms in esophageal cancer cells.
Author: Looby, Eileen|Abdel-Latif, Mohamed M M|Athie-Morales, Veronica|Duggan, Shane|Long, Aideen|Kelleher, Dermot
PMID: 19534809
Journal: Int J Oncol. 2010 Jan;36(1):19-27.
Title: A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer.
Author: Altiok, Soner|Mezzadra, Heather|Jagannath, Sanjay|Tsottles, Nancy|Rudek, Michelle A|Abdallah, Nadia|Berman, David|Forastiere, Arlene|Gibson, Michael K
PMID: 19956829
Journal: J Recept Signal Transduct Res. 2010 Jun;30(3):170-7.
Title: shRNA interference for extracellular signal-regulated kinase 2 can inhibit the growth of esophageal cancer cell line Eca109.
Author: Huo, Qi|Zheng, Shu-tao|Tuersun, Aerziguli|Huang, Cong-gai|Liu, Qing|Zhang, Xue|Sheyhidin, Ilyar|Lu, Xiao-mei
PMID: 20415541
Journal: Mol Biol Rep. 2011 Feb;38(2):865-72.
Title: The expression and activation of ERK/MAPK pathway in human esophageal cancer cell line EC9706.
Author: Zheng, Shu-Tao|Huo, Qi|Tuerxun, Aerziguli|Ma, Wen-Jing|Lv, Guo-Dong|Huang, Cong-Gai|Liu, Qing|Wang, Xing|Lin, Ren-Yong|Sheyhidin, Ilyar|Lu, Xiao-Mei
PMID: 20464500
Journal: Anticancer Agents Med Chem. 2011 Sep;11(7):629-37.
Title: A novel small molecule inhibitor of FAK and IGF-1R protein interactions decreases growth of human esophageal carcinoma.
Author: Ucar, Deniz A|Cox, Audrey|He, Di-Hua|Ostrov, David A|Kurenova, Elena|Hochwald, Steven N
PMID: 21707510
Journal: Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):421-5.
Title: [Expression of ERK1/2 MAPK signaling transduction pathway in esophageal cancers in Kazakh patients].
Author: Zheng, Shu-tao|Liu, Tao|Middottuersun, Aerziguli|Huo, Qi|Liu, Qing|Huang, Cong-gai|Feng, Jun-guo|Lu, Guo-dong|Wang, Xing|Lin, Ren-Yong|Sheyhidin, Ilyar|Lu, Xiao-Mei
PMID: 21875481
Journal: PLoS One. 2011;6(10):e25806.
Title: BRAF mutations in advanced cancers: clinical characteristics and outcomes.
Author: El-Osta, Hazem|Falchook, Gerald|Tsimberidou, Apostolia|Hong, David|Naing, Aung|Kim, Kevin|Wen, Sijin|Janku, Filip|Kurzrock, Razelle
PMID: 22039425
Journal: Pathol Res Pract. 2012 Jul 15;208(7):398-404.
Title: pERK activation in esophageal carcinomas: clinicopathological associations.
Author: Tasioudi, K E|Saetta, A A|Sakellariou, S|Levidou, G|Michalopoulos, N V|Theodorou, D|Patsouris, E|Korkolopoulou, P
PMID: 22658382
Journal: Asian Pac J Cancer Prev. 2012;13(6):2527-32.
Title: Gene silencing of beta-catenin by RNAi inhibits proliferation of human esophageal cancer cells by inducing G0/G1 cell cycle arrest.
Author: Wang, Jin-Sheng|Ji, Ai-Fang|Wan, Hong-Jun|Lu, Ya-Li|Yang, Jian-Zhou|Ma, Li-Li|Wang, Yong-Jin|Wei, Wu
PMID: 22938416
Journal: Mol Carcinog. 2012 Oct;51(10):796-806.
Title: Downregulation of tropomyosin-1 in squamous cell carcinoma of esophagus, the role of Ras signaling and methylation.
Author: Zare, Maryam|Jazii, Ferdous Rastgar|Soheili, Zahra-Soheila|Moghanibashi, Mohamad-Mehdi
PMID: 22965424
Journal: Int J Mol Med. 2012 Dec;30(6):1403-9.
Title: Coxsackievirus and adenovirus receptor promotes antitumor activity of oncolytic adenovirus H101 in esophageal cancer.
Author: Ma, Junfen|Zhao, Jimin|Lu, Jing|Jiang, Yanan|Yang, Hongyan|Li, Pei|Zhao, Mingyao|Liu, Kangdong|Dong, Ziming
PMID: 22992863
Journal: PLoS One. 2013 Oct 9;8(10):e75254.
Title: Inhibiting interleukin-19 activity ameliorates esophageal squamous cell carcinoma progression.
Author: Hsing, Chung-Hsi|Kwok, Franky Antonius|Cheng, Hung-Chi|Li, Chien-Feng|Chang, Ming-Shi
PMID: 24130695
Journal: J Tradit Chin Med. 2013 Jun;33(3):361-6.
Title: Effect of blocking Ras signaling pathway with K-Ras siRNA on apoptosis in esophageal squamous carcinoma cells.
Author: Wang, Xinjie|Zheng, Yuling|Fan, Qingxia|Zhang, Xudong
PMID: 24024333
Journal: Yao Xue Xue Bao. 2013 May;48(5):635-41.
Title: [Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma].
Author: Chang, Yu-Sui|Liu, Ji-Chun|Fu, Hua-Qun|Yu, Ben-Tong|Zou, Shu-Bing|Wu, Qi-Cai|Wan, Li
PMID: 23888683
Journal: Oncol Rep. 2013 Jan;29(1):45-50.
Title: Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer.
Author: Bao, Xiao-Hong|Takaoka, Munenori|Hao, Hui-Fang|Fukazawa, Takuya|Yamatsuji, Tomoki|Sakurama, Kazufumi|Takigawa, Nagio|Nakajima, Motowo|Fujiwara, Toshiyoshi|Naomoto, Yoshio
PMID: 23064324
Journal: Oncol Lett. 2013 Jun;5(6):1872-1876. Epub 2013 Apr 4.
Title: The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109.
Author: Yao, Yuan|Shi, Jingbin|Zhang, Zhuo|Zhang, Feng|Ma, Ruilan|Zhao, Yan
PMID: 23833659
Journal: J Cell Biochem. 2014 Sep;115(9):1624-35.
Title: Obatoclax induces G1/G0-phase arrest via p38/p21(waf1/Cip1) signaling pathway in human esophageal cancer cells.
Author: Zhong, Desheng|Gu, Chunping|Shi, Lili|Xun, Tianrong|Li, Xiaojuan|Liu, Shuwen|Yu, Le
PMID: 24788582
Journal: Int J Mol Sci. 2014 Jul 14;15(7):12422-41.
Title: DADS suppresses human esophageal xenograft tumors through RAF/MEK/ERK and mitochondria-dependent pathways.
Author: Yin, Xiaoran|Zhang, Jun|Li, Xiaoning|Liu, Dong|Feng, Cheng|Liang, Rongrui|Zhuang, Kun|Cai, Chenlei|Xue, Xinghuan|Jing, Fuchun|Wang, Xijing|Wang, Jun|Liu, Xinlian|Ma, Hongbing
PMID: 25026173
Journal: Int J Oncol. 2015 Jan;46(1):299-307.
Title: Combination of SNX-2112 with 5-FU exhibits antagonistic effect in esophageal cancer cells.
Author: Liu, Yuting|Wang, Xiao|Wang, Ying|Zhang, Yi|Zheng, Kai|Yan, Haizhao|Zhang, Li|Chen, Wenbo|Wang, Xiaoyan|Liu, Qiuying|Wang, Shaoxiang|Wang, Yifei
PMID: 25333998
Journal: Oncotarget. 2015 Jan 30;6(3):1790-805.
Title: Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy.
Author: Xu, Wen Wen|Li, Bin|Lam, Alfred K Y|Tsao, Sai Wah|Law, Simon Y K|Chan, Kwok Wah|Yuan, Qiu Ju|Cheung, Annie L M
PMID: 25595897
Journal: Onco Targets Ther. 2015 Feb 25;8:509-18.
Title: Nimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.
Author: Liu, Hai|Yang, Weifang|Gao, Huaping|Jiang, Tingting|Gu, Bengxin|Dong, Qinghua|Xu, Wenhong|Wu, Shixiu|Sun, Xiaonan
PMID: 25750543
Journal: Chin J Nat Med. 2015 Jun;13(6):428-37.
Title: Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway.
Author: Fan, Wei|Sun, Li|Zhou, Jing-Qian|Zhang, Cang|Qin, Song|Tang, Ying|Liu, Yang|Lin, Sen-Sen|Yuan, Sheng-Tao
PMID: 26073339
Journal: Oncotarget. 2015 Jul 30;6(21):18674-82.
Title: High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.
Author: Wang, Chun-yu|Deng, Jia-ying|Cai, Xu-wei|Fu, Xiao-long|Li, Yuan|Zhou, Xiao-yan|Wu, Xiang-hua|Hu, Xi-chun|Fan, Min|Xiang, Jia-qing|Zhang, Ya-wei|Chen, Hai-quan|Perez, Rolando|Jiang, Guo-liang|Zhao, Kuai-le
PMID: 26124180
Journal: Int J Clin Exp Pathol. 2015 May 1;8(5):5080-8. eCollection 2015.
Title: Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
Author: Zhan, Zheng-Yu|Zhong, Lu-Xing|Feng, Miao|Wang, Jian-Feng|Liu, Di-Bin|Xiong, Jian-Ping
PMID: 26191202
Journal: Oncotarget. 2016 Jan 12;7(2):1826-37.
Title: Griffipavixanthone, a dimeric xanthone extracted from edible plants, inhibits tumor metastasis and proliferation via downregulation of the RAF pathway in esophageal cancer.
Author: Ding, Zhijie|Lao, Yuanzhi|Zhang, Hong|Fu, Wenwei|Zhu, Lunlun|Tan, Hongsheng|Xu, Hongxi
PMID: 26646323
Journal: Zhonghua Zhong Liu Za Zhi. 2016 May 23;38(5):325-32.
Title: [Effect of bufalin on proliferation and apoptosis through ERK/RSK2 pathway in human esophageal carcinoma cell line xenografts in nude mice].
Author: Yue, M|Liu, X J|Ding, Y|Wang, X L|Yang, H C|Liu, Y P
PMID: 27188603
Journal: Oncol Lett. 2016 Sep;12(3):2232-2238.
Title: Aloe-emodin suppresses esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK phosphorylation.
Author: Chang, Xiaobin|Zhao, Jimin|Tian, Fang|Jiang, Yanan|Lu, Jing|Ma, Junfen|Zhang, Xiaoyan|Jin, Guoguo|Huang, Youtian|Dong, Zigang|Liu, Kangdong|Dong, Ziming
PMID: 27602169
Journal: Gastroenterology. 2017 Jun;152(8):1985-1997.e12.
Title: Solute Carrier Family 39 Member 6 Gene Promotes Aggressiveness of Esophageal Carcinoma Cells by Increasing Intracellular Levels of Zinc, Activating Phosphatidylinositol 3-Kinase Signaling, and Up-regulating Genes That Regulate Metastasis.
Author: Cheng, Xinxin|Wei, Lixuan|Huang, Xudong|Zheng, Jian|Shao, Mingming|Feng, Ting|Li, Jun|Han, Yaling|Tan, Wenle|Tan, Wen|Lin, Dongxin|Wu, Chen
PMID: 28209530
Journal: Drug Deliv. 2017 Nov;24(1):1549-1564.
Title: GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Author: Pi, Jiang|Jiang, Jinhuan|Cai, Huaihong|Yang, Fen|Jin, Hua|Yang, Peihui|Cai, Jiye|Chen, Zheng W
PMID: 29019267
Journal: Ann Thorac Surg. 2018 Feb;105(2):363-370.
Title: HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.
Author: Goltsov, Alexei A|Fang, Bingliang|Pandita, Tej K|Maru, Dipen M|Swisher, Stephen G|Hofstetter, Wayne L
PMID: 29223420
Journal: Cancer Lett. 2018 Apr 1;418:97-108.
Title: Down-regulation of RIP3 potentiates cisplatin chemoresistance by triggering HSP90-ERK pathway mediated DNA repair in esophageal squamous cell carcinoma.
Author: Sun, Yulin|Zhai, Linhui|Ma, Shouzhi|Zhang, Chengpu|Zhao, Lina|Li, Ning|Xu, Yang|Zhang, Tao|Guo, Zhimin|Zhang, Heng|Xu, Ping|Zhao, Xiaohang
PMID: 29331417
Journal: Mol Med Rep. 2018 Apr;17(4):5362-5367.
Title: Cullin7 promotes epithelialmesenchymal transition of esophageal carcinoma via the ERKSNAI2 signaling pathway.
Author: Tian, Ping|Liu, Dandan|Sun, Luyi|Sun, Hui
PMID: 29393450
Journal: Hum Pathol. 2018 May;75:116-124.
Title: Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers.
Author: Li, Guanhua|Dong, Taotao|Yang, Dong|Gao, Aiqin|Luo, Judong|Yang, Hongyan|Wang, Linlin
PMID: 29452214
Journal: Gastroenterology. 2018 Jun;154(8):2137-2151.e1.
Title: Super-Enhancer-Driven Long Non-Coding RNA LINC01503, Regulated by TP63, Is Over-Expressed and Oncogenic in Squamous Cell Carcinoma.
Author: Xie, Jian-Jun|Jiang, Yan-Yi|Jiang, Yuan|Li, Chun-Quan|Lim, Mei-Chee|An, Omer|Mayakonda, Anand|Ding, Ling-Wen|Long, Lin|Sun, Chun|Lin, Le-Hang|Chen, Li|Wu, Jian-Yi|Wu, Zhi-Yong|Cao, Qi|Fang, Wang-Kai|Yang, Wei|Soukiasian, Harmik|Meltzer, Stephen J|Yang, He
PMID: 29454790
Journal: Oncotarget. 2018 Jan 10;9(10):9425-9441.
Title: Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NF-kB/COX-2/VEGF axis.
Author: Huang, Chien-Yu|Lee, Chia-Hwa|Tu, Chao-Chiang|Wu, Chih-Hsiung|Huang, Ming-Te|Wei, Po-Li|Chang, Yu-Jia
PMID: 29507700
Journal: Molecules. 2018 Apr 17;23(4). pii: molecules23040930.
Title: Chemoresistance to Cancer Treatment: Benzo-alpha-Pyrene as Friend or Foe?
Author: Dzobo, Kevin|Hassen, Naseeha|Senthebane, Dimakatso Alice|Thomford, Nicholas Ekow|Rowe, Arielle|Shipanga, Hendrina|Wonkam, Ambroise|Parker, M Iqbal|Mowla, Shaheen|Dandara, Collet
PMID: 29673198
Journal: Oncol Rep. 2018 Jun;39(6):2942-2950.
Title: Eupatilin inhibits the proliferation of human esophageal cancer TE1 cells by targeting the AktGSK3beta and MAPK/ERK signaling cascades.
Author: Wang, Xiaona|Zhu, Yanyan|Zhu, Lili|Chen, Xinhuan|Xu, Yanyan|Zhao, Yafei|Shao, Yingzhe|Li, Feng|Jiang, Yanan|Lu, Jing|Huang, Youtian|Chang, Xiaobin|Zhang, Juan|Li, Xiang|Liu, Kangdong|Zhao, Mingyao|Dong, Ziming|Zhao, Jimin
PMID: 29693162
Journal: Cancer Res. 2018 Sep 1;78(17):4957-4970.
Title: IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment.
Author: Karakasheva, Tatiana A|Lin, Eric W|Tang, Qiaosi|Qiao, Edmund|Waldron, Todd J|Soni, Monica|Klein-Szanto, Andres J|Sahu, Varun|Basu, Devraj|Ohashi, Shinya|Baba, Kiichiro|Giaccone, Zachary T|Walker, Sarah R|Frank, David A|Wileyto, E Paul|Long, Qi|Dunagin, Ma
PMID: 29976575
Journal: Cell Death Dis. 2018 Jul 26;9(8):817.
Title: Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways.
Author: Cao, Jinlin|Lv, Wang|Wang, Luming|Xu, Jinming|Yuan, Ping|Huang, Sha|He, Zhehao|Hu, Jian
PMID: 30050135
Journal: J Agric Food Chem. 2018 Sep 5;66(35):9248-9258.
Title: Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling.
Author: Xu, Wen Wen|Zheng, Can-Can|Huang, Yun-Na|Chen, Wen-You|Yang, Qing-Sheng|Ren, Jia-Yi|Wang, Yue-Ming|He, Qing-Yu|Liao, Hua-Xin|Li, Bin
PMID: 30113849
Journal: Cell Physiol Biochem. 2018;49(1):217-225.
Title: RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Author: Lu, Huibin|Jiang, Tian|Ren, Kewei|Li, Zongming Li|Ren, Jianzhuang|Wu, Gang|Han, Xinwei
PMID: 30138923